Article
Decision reversed: Medicare will not pay for OPT in occult wet AMD
Washington, DC-Citing concerns about safety and long-term benefits, the U.S. Centers for Medicare and Medicaid Services (CMS) has reversed its October 2001 decision to reimburse patients who receive ocular photodynamic therapy (PCT)
Related Videos
Related Content
